Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kohei Shiroshita"'
Autor:
Miki Sakamoto, Kohei Shiroshita, Shinya Fujita, Himari Kudo, Ryohei Abe, Sumiko Kohashi, Yuka Shiozawa, Kuniaki Nakanishi, Takaaki Toyama
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 638-641 (2024)
Externí odkaz:
https://doaj.org/article/31cfd2fe2edc498388b71be1181768fd
Autor:
Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Shinya Fujita, Takayuki Morikawa, Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Miho Haraguchi, Shinpei Tamaki, Takehiro Yamamoto, Tomohiro Yabushita, Yosuke Tanaka, Go Nagamatsu, Hiroaki Honda, Shinichiro Okamoto, Nobuhito Goda, Tomohiko Tamura, Ayako Nakamura-Ishizu, Makoto Suematsu, Atsushi Iwama, Toshio Suda, Keiyo Takubo
Publikováno v:
eLife, Vol 13 (2024)
Externí odkaz:
https://doaj.org/article/680b6773601a457c9f522daee233063f
Autor:
Kohei Shiroshita, Sumiko Kohashi, Miki Sakamoto, Himari Kudo, Kuniaki Nakanishi, Takaaki Toyama
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 629-630 (2024)
Externí odkaz:
https://doaj.org/article/10ab3cccf4734bcd8e421f4914aae30a
Autor:
Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Shinya Fujita, Takayuki Morikawa, Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Miho Haraguchi, Shinpei Tamaki, Takehiro Yamamoto, Tomohiro Yabushita, Yosuke Tanaka, Go Nagamatsu, Hiroaki Honda, Shinichiro Okamoto, Nobuhito Goda, Tomohiko Tamura, Ayako Nakamura-Ishizu, Makoto Suematsu, Atsushi Iwama, Toshio Suda, Keiyo Takubo
Publikováno v:
eLife, Vol 12 (2024)
Metabolic pathways are plastic and rapidly change in response to stress or perturbation. Current metabolic profiling techniques require lysis of many cells, complicating the tracking of metabolic changes over time after stress in rare cells such as h
Externí odkaz:
https://doaj.org/article/463ed22c3cf443bbbb65ad6b8298905f
Publikováno v:
STAR Protocols, Vol 4, Iss 2, Pp 102347- (2023)
Summary: Preculture is indispensable for achieving highly efficient non-homologous end joining (NHEJ)-based genome editing. Here, we present a protocol for optimizing genome editing conditions for murine hematopoietic stem cells (HSCs) and evaluating
Externí odkaz:
https://doaj.org/article/9c78dc7d9f4b4a619e73bd3e6649db1f
Autor:
Shinya Fujita, Hidenori Kasahara, Jun Kato, Yuya Koda, Kohei Shiroshita, Kentaro Yamaguchi, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1549-1562, 14p
Autor:
Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Miho Haraguchi, Shinpei Tamaki, Takehiro Yamamoto, Tomohiro Yabushita, Yosuke Tanaka, Hiroaki Honda, Shinichiro Okamoto, Nobuhito Goda, Tomohiko Tamura, Ayako Nakamura-Ishizu, Makoto Suematsu, Atsushi Iwama, Toshio Suda, Keiyo Takubo
Metabolic pathways are plastic and rapidly change in response to stress or perturbation. Current metabolic profiling techniques require lysis of many cells, complicating the tracking of metabolic changes over time after stress in rare cells such as h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfd042463602f7794121f80c43228aab
https://doi.org/10.7554/elife.87674
https://doi.org/10.7554/elife.87674
Autor:
Kohei Shiroshita, Mikio Okayama, Hiroki Soma, Yuki Sato, Hiroyoshi Hayashi, Yuka Shiozawa, Shinichiro Okamoto, Ken Sadahira
Publikováno v:
Clinical Hematology International.
Pulmonary embolism and deep venous thrombosis (PE/DVT) are well-known lethal complications in autoimmune hemolytic anemia (AIHA). However, the impact of their treatment is unclear. Here, we describe three elderly Japanese patients with AIHA who devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b31ab6509bb3f9900fef6b1070cfd349
https://doi.org/10.1007/s44228-023-00043-9
https://doi.org/10.1007/s44228-023-00043-9
Autor:
Shinya Fujita, Masatoshi Sakurai, Hidenori Kasahara, Jun Kato, Yuya Koda, Kentaro Yamaguchi, Kohei Shiroshita, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Second- and third-generation (2/3G) tyrosine kinase inhibitors (TKIs) possess excellent treatment effects on chronic myeloid leukemia (CML), and at least one 2/3G TKI is mostly incorporated into the first treatment of CML in all phases. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7f3963727f09ecbe84d03b40fc7f25
https://doi.org/10.21203/rs.3.rs-2050971/v1
https://doi.org/10.21203/rs.3.rs-2050971/v1
Autor:
Keiyo Takubo, Phyo Wai Htun, Takeshi Ueda, Yasuyuki Sera, Masayuki Iwasaki, Miho Koizumi, Kohei Shiroshita, Hiroshi Kobayashi, Miho Haraguchi, Shintaro Watanuki, Zen-ichiro Honda, Norimasa Yamasaki, Ayako Nakamura-Ishizu, Fumio Arai, Noboru Motoyama, Tomohisa Hatta, Tohru Natsume, Toshio Suda, Hiroaki Honda
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 8/8/2023, Vol. 120 Issue 32, p1-10, 39p